<DOC>
	<DOCNO>NCT00733460</DOCNO>
	<brief_summary>Safety dosimetry BFPET™ evaluate healthy volunteer Coronary Artery Disease ( CAD ) patient , male female age range 20-80 year old .</brief_summary>
	<brief_title>A Phase I Study Evaluate BFPET Potential Myocardial Perfusion Imaging ( MPI ) Agent PET</brief_title>
	<detailed_description>Study Procedures : Visit 1 : Screening - Eligibility determination Visit 2 ( within 14 day post screen ) : Injection BFPET™ PET Imaging Visit 3 ( within 24-48 hour post dose ) : Follow-up Visit</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>NORMAL HEALTHY VOLUNTEERS Inclusion Criteria 1 . Subject must provide write informed consent prior study related procedure ; 2 . Subject must ≥ 20 ≤ 80 year age ; 3 . Subject must serum creatinine within investigational site 's normal range . 4 . Subject must liver function test &lt; 1.5 time investigational site 's normal range . 5 . Subject must hematocrit level within 5 % investigational site 's normal range . 1 . Any clinically significant acute unstable physical psychological disease base medical history screen physical examination ; 2 . Any clinically significant abnormality screen laboratory test ECG ; 3 . Any exposure investigational drug within four ( 4 ) week prior Visit 1 ; 4 . Any exposure investigational radiopharmaceutical within four ( 4 ) week prior date Visit 1 ; 5 . Any new prescription medication within four ( 4 ) week Visit 1 ; 6 . Subject Positive ( + ) Serum Pregnancy Test , possibility pregnancy rule prior dose breastfeed . There standard pregnancy procedure use radiopharmaceutical research MGH . 7 . Subject experience allergic reaction similar radiofluorinated compound agent . CORONARY ARTERY DISEASE ( CAD ) SUBJECTS 1 . Subjects must provide write informed consent prior study related procedure ; 2 . Subjects must ≥ 20 ≤ 80 year age ; 3 . Subjects must history CAD document abnormal stress myocardial perfusion imaging ( MPI ) study cardiac catheterization within 6 month BFPET studyExclusion Criteria 1 . Subject Positive ( + ) Serum and/or Urine Pregnancy Test lactating , possibility pregnancy rule prior dose ; 2 . Any clinically significant acute unstable physical psychological disease judge investigator base medical history screen physical examination ; 3 . Coronary artery bypass graft ( CABG ) within 6 month ; 4 . Percutaneous coronary intervention ( PCI ) , stent placement within six month ; 5 . Blood pressure 180/100 ; 6 . Acute change ECG ; 7 . Recent ( within 3 month ) cardiac arrest , unstable angina , myocardial infarction , cerebrovascular accident ( CVA ) , general anesthesia procedure , surgical procedure ; 8 . Any implanted pacemaker defibrillator use within last three month ; 9 . Inability remain camera approximately 60 minute ( Smokers COPD include long breath PET camera take O2 nasal canula ) ; 10 . History Diabetes Mellitus ; 11 . Serum creatinine &gt; 2 mg/dL ; 12 . All cancer patient ; 13 . Body Mass Index ( BMI ) 35 ; 14 . Any exposure investigational drug medical device within four ( 4 ) week prior image study ; 15 . Any exposure radiopharmaceutical within four ( 4 ) week prior date imaging study ;</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>BFPET</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Myocardial Perfusion Imaging</keyword>
	<keyword>Radiation Dosimetry</keyword>
</DOC>